×
About 593 results

ALLMedicine™ Pediatric Heart Transplantation Center

Research & Reviews  226 results

Pediatric heart transplantation: The past, the present, and the future.
https://doi.org/10.1016/j.sempedsurg.2022.151176
Seminars in Pediatric Surgery; Greenberg JW, Guzman-Gomez A et. al.

Jun 21st, 2022 - Heart transplantation (HTx) has a storied past, with origins dating back to the early twentieth century and the first pediatric orthotopic heart transplant performed in 1967 on a neonate with Ebstein abnormality. Today, approximately 500 pediatric...

Tricuspid Annular Plane Systolic Excursion (TAPSE) correlates with mean pulmonary arter...
https://doi.org/10.1111/ctr.14710
Clinical Transplantation; Michalski M, Haas N et. al.

May 17th, 2022 - Tricuspid annular plane systolic excursion (TAPSE) is important in the noninvasive echocardiographic assessment of right heart function. This retrospective observational study shows correlations of TAPSE with invasive right heart catheterization p...

Protein-losing enteropathy recurrence after pediatric heart transplantation: Multicente...
https://doi.org/10.1111/petr.14295
Pediatric Transplantation; Sagray E, Johnson JN et. al.

Apr 23rd, 2022 - Protein-losing enteropathy (PLE) is a devastating complication of the Fontan circulation. Although orthotopic heart transplantation (HTx) typically results in resolution of PLE symptoms, isolated cases of PLE relapse have been described after HTx....

Pediatric heart transplantation in infants and small children under 3 years of age: Sin...
https://doi.org/10.1016/j.ijcard.2022.04.002
International Journal of Cardiology; Rosenthal LL, Ulrich SM et. al.

Apr 9th, 2022 - We analyzed the early and long-term survival after ABO-compatible heart transplantation in children under 3 years of age from 1991 to 2021 at our center. This retrospective and descriptive study aimed to identify serious adverse events associated ...

Association Between Cytomegalovirus Serostatus, Antiviral Therapy, and Allograft Surviv...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964945
Transplant International : Official Journal of the Europe... Rabbani N, Kronmal RA et. al.

Apr 5th, 2022 - Background: Cytomegalovirus (CMV) is an important complication of heart transplantation and has been associated with graft loss in adults. The data in pediatric transplantation, however, is limited and conflicting. We conducted a large-scale cohor...

see more →

Clinicaltrials.gov  7 results

Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
https://clinicaltrials.gov/ct2/show/NCT03386539

Sep 5th, 2021 - Median survival after pediatric heart transplantation (HT) is 15 years in the current era. This means that a substantial fraction of patients transplanted during childhood fail to survive to adulthood, or require heart re-transplantation, because ...

Pediatric Heart Transplantation: Transitioning to Adult Care
https://clinicaltrials.gov/ct2/show/NCT02090257

Jul 26th, 2017 - The purpose of this pilot trial, Transitioning to Adult Care (TRANSIT), is to develop and test an intervention (i.e., a standardized, tailored transition program focused on enhancing adherence) to improve outcomes for emerging adults who underwent...

Alloantibodies in Pediatric Heart Transplantation
https://clinicaltrials.gov/ct2/show/NCT01005316

Apr 20th, 2017 - There is currently a renewed interest in alloantibodies in transplantation. In 1966, Kissmeyer and colleagues reported that pre-existing antibodies directed against donor cells could cause hyperacute rejection of the renal allograft. Three years l...

Thymic Tolerance in Pediatric Heart Transplantation
https://clinicaltrials.gov/ct2/show/NCT00151164

Jul 12th, 2016 - The investigators hypothesize that injecting donor bone marrow cells into the recipient thymus gland at the time of heart transplantation in children will prove to be feasible and safe. They further hypothesize that recipients receiving donor bone...

Coronary Artery Study in Pediatric Heart Transplantation
https://clinicaltrials.gov/ct2/show/NCT01546870

Jun 20th, 2016 - Transplant coronary artery disease (TCAD) is a significant cause of morbidity and mortality in pediatric heart transplantation (PHT). Understanding the pathophysiology and early detection along with attempted medical management are crucial in prev...

see more →

News  4 results

Changing Indications in Pediatric Transplants
https://www.mdedge.com/cardiology/article/42173/interventional-cardiology-surgery/changing-indications-pediatric
Mark S. Lesney

Apr 1st, 2011 - Major Finding: Survival was best in patients who were transplanted for cardiomyopathy (1-, 3-, 5-, and 10-year survival of 90%, 84%, 81%, and 81%, respectively) and worst in patients with failed palliations for SV anomalies, especially failed Font.

Changing Indications In Pediatric Transplants
https://www.mdedge.com/content/changing-indications-pediatric-transplants-0
Mark S. Lesney

Mar 1st, 2011 - SAN DIEGO - Over the past 24 years, the prevalence of indications for pediatric heart transplantation resulting from congenital heart disease has changed. Transplantation for failed SV palliation, including failed Fontan procedure, has now become.

Changing Indications in Pediatric Heart Transplants
https://www.mdedge.com/content/changing-indications-pediatric-heart-transplants-0
Mark S. Lesney

Feb 15th, 2011 - SAN DIEGO – Over the past 24 years, the prevalence of indications for pediatric heart transplantation resulting from congenital heart disease has changed. Transplantation for failed SV palliation, including failed Fontan procedure, has now become.

Changing Indications in Pediatric Heart Transplants
https://www.mdedge.com/internalmedicine/article/24632/adolescent-medicine/changing-indications-pediatric-heart-transplants
Mark S. Lesney

Feb 15th, 2011 - SAN DIEGO – Over the past 24 years, the prevalence of indications for pediatric heart transplantation resulting from congenital heart disease has changed. Transplantation for failed SV palliation, including failed Fontan procedure, has now become.

see more →